# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Neurofibromatosis type 2

Neurofibromatosis 2 (NF2)Bilateral Acoustic NeurofibromatosisBANF Acoustic Neurinoma
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 14 results.
A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)
Status: Recruiting
Last Changed: Oct 15, 2018
First Received: Sep 17, 2018
Disease(s): Neurofibromatosis 1 and 2 (NF1 and NF2)
Intervention(s): hand-held dynamometer
Locations: New York School of Medicine, New York, New York, United States
Natural History Study of Patients With Neurofibromatosis Type 2
Status: Recruiting
Last Changed: Oct 30, 2019
First Received: Jan 21, 2008
Disease(s): Spinal Cord Disease, Intracranial Central Nervous System Disorder, Neurologic Disorders, Brain Neoplasms
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors
Status: Recruiting
Last Changed: Oct 08, 2019
First Received: Mar 29, 2017
Disease(s): Neurofibromatosis 2, Vestibular Schwannoma, Meningioma, Ependymoma, Glioma
Intervention(s): Selumetinib
Locations: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15
Status: Recruiting
Last Changed: Mar 28, 2019
First Received: Mar 28, 2019
Disease(s): Neurofibromatosis 2, Dermatology/Skin - Other
Intervention(s): no intervention
Locations: Nice Hospital, Nice, France
Resiliency Training in Adolescents With NF1 and NF2
Status: Not yet recruiting
Last Changed: Oct 08, 2019
First Received: Mar 13, 2019
Disease(s): Neurofibromatoses
Intervention(s): Stress and Symptom Management Program 1, Stress and Symptom Management Program 2
Locations: Massachusetts General Hospital, Boston, Massachusetts, United States
Neurofibromatosis (NF) Registry Portal
Status: Recruiting
Last Changed: Feb 04, 2019
First Received: Jun 25, 2013
Disease(s): Neurofibromatosis 1, Neurofibromatosis 2, Schwannomatosis
Locations: Children's Tumor Fundation, New York, New York, United States
Study of Aspirin in Patients With Vestibular Schwannoma
Status: Recruiting
Last Changed: Aug 09, 2019
First Received: Mar 15, 2017
Disease(s): Vestibular Schwannoma, Acoustic Neuroma, Neurofibromatosis 2
Intervention(s): Aspirin, Placebo
Locations: Stanford Otolaryngology/HNS, Stanford, California, United States
University of Iowa, Iowa City, Iowa, United States
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Mayo Clinic, Rochester, Minnesota, United States
... and 2 other locations.
Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing
Status: Recruiting
Last Changed: Jan 23, 2018
First Received: Jan 23, 2018
Disease(s): Neurofibromatoses, Neurofibromatosis 1, Neurofibromatosis 2, Schwannomatosis
Intervention(s): Stress and Symptom Management Program 1, Stress and Symptom Management Program 2
Locations: Massachusetts General Hospital, Boston, Massachusetts, United States
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
Status: Recruiting
Last Changed: Sep 17, 2019
First Received: Mar 13, 2012
Disease(s): Advanced Malignant Neoplasm, Castleman Disease, Digestive System Carcinoma, Erdheim-Chester Disease, Lip and Oral Cavity Carcinoma, Lymphangioleiomyomatosis, Malignant Endocrine Neoplasm, Malignant Female Reproductive System Neoplasm, Malignant Male Reproductive System Neoplasm, Malignant Neoplasm, Malignant Respiratory Tract Neoplasm, Malignant Thoracic Neoplasm, Malignant Urinary System Neoplasm, Mesothelial Neoplasm, Metastatic Malignant Neoplasm, Metastatic Urothelial Carcinoma, Neurofibromatosis Type 2, Recurrent Adult Soft Tissue Sarcoma, Recurrent Breast Carcinoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Digestive System Carcinoma, Recurrent Female Reproductive System Carcinoma, Recurrent Male Reproductive System Carcinoma, Recurrent Malignant Neoplasm, Recurrent Pharyngeal Carcinoma, Recurrent Thyroid Gland Carcinoma, Refractory Malignant Neoplasm, Soft Tissue Neoplasm, Stage III Breast Cancer AJCC v7, Stage III Pharyngeal Cancer, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7, Stage IV Pharyngeal Cancer, Stage IVA Pharyngeal Cancer, Stage IVB Pharyngeal Cancer, Stage IVC Pharyngeal Cancer, Thyroid Gland Neoplasm
Intervention(s): Bevacizumab, Cetuximab, Laboratory Biomarker Analysis, Pharmacological Study, Temsirolimus, Valproic Acid
Locations: M D Anderson Cancer Center, Houston, Texas, United States
Familial Investigations of Childhood Cancer Predisposition
Status: Recruiting
Last Changed: Apr 26, 2019
First Received: Feb 10, 2017
Disease(s): Acute Leukemia, Adenomatous Polyposis, Adrenocortical Carcinoma, AML, BAP1 Tumor Predisposition Syndrome, Carney Complex, Choroid Plexus Carcinoma, Constitutional Mismatch Repair Deficiency Syndrome, Diamond-Blackfan Anemia, DICER1 Syndrome, Dyskeratosis Congenita, Emberger Syndrome, Familial Acute Myeloid Leukemia, Familial Adenomatous Polyposis, Fanconi Anemia, Familial Cancer, Familial Wilms Tumor, Familial Neuroblastoma, GIST, Hereditary Breast and Ovarian Cancer, Hereditary Paraganglioma-Pheochromocytoma Syndrome, Hodgkin Lymphoma, Juvenile Polyposis, Li-Fraumeni Syndrome, Lynch Syndrome, MDS, Melanoma Syndrome, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2, Neuroblastoma, Neurofibromatosis Type 1, Neurofibromatosis Type II, Nevoid Basal Cell Carcinoma Syndrome, Non Hodgkin Lymphoma, Noonan Syndrome and Other Rasopathy, Overgrowth Syndromes, Pancreatic Cancer, Peutz-Jeghers Syndrome, Pheochromocytoma/Paraganglioma, PTEN Hamartoma Tumor Syndrome, Retinoblastoma, Rhabdoid Tumor Predisposition Syndrome, Rhabdomyosarcoma, Rothmund-Thomson Syndrome, Tuberous Sclerosis, Von Hippel-Lindau Disease
Locations: St. Jude Children's Research Hospital, Memphis, Tennessee, United States